Union Health

Accountable Care Organizations (ACOs) are groups of doctors, hospitals, and other health care providers, who come together voluntarily to give coordinated high quality care to their Medicare patients. The goal of coordinated care is to ensure that patients, especially the chronically ill, get the right care at the right time, while avoiding unnecessary duplication of services and preventing medical errors. When an ACO succeeds both in delivering high-quality care and spending health care dollars more wisely, it will share in the savings it achieves for the Medicare program. ACOs, work with Medicare to find new ways to provide you with the highest quality of medical care. 

For general questions or additional information about Accountable Care Organizations, please visit www.medicare.gov/acos.html or call 1-800-MEDICARE (1-800-633-4227) TTY users should call 1-877-486-2048.

ACO Name and Location:

Union Health ACO
1606 N. 7th St.
Terre Haute, IN 47082

ACO Primary Contact:

Lennie Wilson
This email address is being protected from spambots. You need JavaScript enabled to view it.
(812) 238-4704

Organizational Information:

ACO participants:

  • Union Hospital, Inc.
  • Union Associated Physicians Clinic, LLC
  • Providence Medical Group, LLC
  • Cork Medical Center
  • Clay City Center For Family Medicine
  • Valley Professionals Community Health Center, Inc.

ACO participants in joint ventures between ACO professionals and hospitals:

No participants involved in a joint venture between ACO professionals and hospitals.

ACO Governing Body:

  • Steve Holman, ACO Chairperson, Union Hospital
  • Steve McDonald, M.D., ACO Provider/Supplier, Valley Professionals
  • George Bittar, M.D. ACO Provider/Supplier, Providence Medical Group
  • Hans Andreasen, M.D. ACO Provider/Supplier, Union Associated Physicians Clinic
  • Terry Warren, ACO Provider/Supplier, Valley Professionals
  • John Bolinger, D.O. ACO Provider/Supplier, Union Hospital
  • Douglas Gillespie, M.D., ACO Provider/Supplier, Union Hospital
  • John Dinkel, Medicare Beneficiary Representative
  • Wayne Hutson, ACO Participant, Union Hospital

Key ACO clinical and administrative leadership:

  • ACO Executive, Lennie Wilson
  • Medical Director, Douglas Gillespie, M.D.
  • Compliance Officer, Lori Moon
  • Quality Assurance/Improvement Officer, Debbie Stuck

Associated committees and committee leadership

  • Chair, Professional Services Committee, John Bolinger, D.O.
  • Chair, Finance and Operations Committee, Wayne Hutson

Types of ACO participants or combinations of participants that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Network of individual practices of ACO professionals
  • Partnership or joint venture arrangement between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Agreement period beginning Year 1, Performance Year 1: $0
  • Agreement period beginning Year 1, Performance Year 2014: $0
  • Agreement period beginning Year 1, Performance Year 2015: $0

Shared Savings Distributions

  • Agreement period beginning Year 1, Performance Year 1: $0
  • Agreement period beginning Year 1, Performance Year 2014: $0
  • Agreement period beginning Year 1, Performance Year 2015: $0

Quality Performance Results

Measure number​              Measure Name2015 Reporting Period
                           ​
    ACO Performance Rate Mean Performance Rate (SSP-ACOs)
​(ACO-1) ​Getting Timely Care, Appointments, and Information   86.02 80.61
​(ACO-2) ​How Well Your Doctors Communicate  94.18  ​92.65
​(ACO-3) ​Patients’ Rating of Doctor  93.81 ​91.94
​(ACO-4) ​Access to Specialists 85.17  ​83.61
​(ACO-5) ​Health Promotion and Education  55.06  ​59.06
​(ACO-6) ​Shared Decision Making  74.64  ​75.17
​(ACO-7) ​Health Status/Functional Status
71.25  ​72.30
(ACO-34)​ ​Stewardship of Patient Resources* 33.64  ​26.87
(ACO-8)​ ​Risk Standardized, All Condition Readmissions  14.87  14.86
​(ACO-35) ​Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)* Readmission  18.79 18.07
​(ACO-36) All-Cause Unplanned Admissions for Patients with Diabetes*  58.83 54.60
​(ACO-37) ​All-Cause Unplanned Admissions for Patients with Heart Failure*  83.66 54.60
​(ACO-38) ​All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 66.44 76.96
​(ACO-9) Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)  1.31 1.11
(ACO-10)​ Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) 1.04  ​1.04
​(ACO-11) Percent of Primary Care Physicians who Successfully Meet Meaningful Use Requirements  100.00 76.22
​(ACO-39) ​Documentation of Current Medications in the Medical Record* 87.99  84.02
​(ACO-13)​ ​Falls: Screening for Future Fall Risk   68.99 56.46
​(ACO-14)​ Preventive Care and Screening: Influenza Immunization  72.61 62.03
​(ACO-15) Pneumonia Vaccination Status for Older Adults 71.99  63.73
​(ACO-16) Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up 51.69  ​71.15
(ACO-17)​ Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 94.23  90.16
​(ACO-18) Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 55.21  45.25
​(ACO-19) ​Colorectal Cancer Screening  70.68 60.06
​(ACO-20) ​Breast Cancer Screening   65.35 65.67
(ACO-21)​ Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 0.00  70.04
​(ACO-40) Depression Remission at Twelve Months* N/A N/A
​(ACO-27) Diabetes Mellitus: Hemoglobin A1c Poor Control  16.11 20.38
​(ACO-41) Diabetes: Eye Exam* 50.34  41.05
​(ACO-28) Hypertension: Controlling High Blood Pressure 74.17  69.62
​(ACO-30) Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic 93.59  83.82
​(ACO-31) Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 95.42  87.22
​(ACO-33) Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)  81.58 77.73
CAHPS = Consumer Assessment of Healthcare Providers and Systems, PQI = Prevention Quality Indicator, LVSD = left ventricular systolic dysfunction, ACE = angiotensin-converting enzyme, ARB = angiotensin receptor blocker, CAD = coronary artery disease.
*= Measure required beginning Reporting Year 2015.
N/A= Reporting on the depression remission measure is not required for 2015, as indicated by N/A

2013-2014 Performance Summary Statistics

Measure number​              ​Performance Measure​Performance Year 1 
Summary Statistics     
                           ​
Performance Year 2 
Summary Statistics ​
    ACO Performance Rate Mean Performance Rate for All ACOs​
ACO Performance Rate
Mean Performance Rate for All ACOs​
​(ACO-1) ​Getting Timely Care, Appointments, and Information  not in operations ​not in operations ​83.04 ​80.13
​(ACO-2) ​How Well Your Doctors Communicate  not in operations ​not in operations ​92.86 ​92.39
​(ACO-3) ​Patients’ Rating of Doctor  not in operations ​not in operations ​92.75 ​91.58
​(ACO-4) ​Access to Specialists not in operations ​not in operations ​87.42 ​83.97
​(ACO-5) ​Health Promotion and Education  not in operations ​not in operations ​51.09 ​58.29
​(ACO-6) ​Shared Decision Making  not in operations ​not in operations ​72.97 ​74.6
​(ACO-7) ​Health Status/Functional Status
not in operations ​not in operations ​72.92 ​71.1
(ACO-8)​ ​Risk Standardized, All Condition Readmissions  ​14.59 ​14.90 ​15.36 ​15.15
​(ACO-9) ​ASC Admissions: COPD or Asthma in Older Adults  ​1.36 ​1.17 ​1.15 ​1.08
(ACO-10)​ ​ASC Admission: Heart Failure  ​1.17 ​1.20
.95
​1.19
​(ACO-11) ​Percent of Primary Care Providers who Qualified for EHR Incentive Payment  ​72.00% ​ 66.21%​
78.57%
​76.71%
​(ACO-12) ​Medication Reconciliation  not in operations ​not in operations ​99.70 ​82.61
​(ACO-13)​ ​Falls: Screening for Fall Risk  not in operations ​not in operations ​ 42.62 ​45.6
​(ACO-14)​ ​Influenza Immunization  not in operations ​not in operations ​62.44 ​57.51
​(ACO-15) ​Pneumococcal Vaccination  not in operations ​not in operations ​62.77 ​55.03
​(ACO-16) ​Adult Weight Screening and Follow-up

not in operations ​not in operations ​49.34 ​66.75
(ACO-17)​ ​Tobacco Use Assessment and Cessation Intervention  not in operations ​not in operations ​98.01 ​86.79
​(ACO-18) ​Depression Screening   not in operations ​not in operations ​41.00 ​39.27
​(ACO-19) ​Colorectal Cancer Screening  not in operations ​not in operations ​57.68 ​56.14
​(ACO-20) ​Mammography Screening  not in operations ​not in operations ​65.30 ​61.41
​Proportion of Adults who had blood pressure screened in past two years not in operations ​not in operations ​99.67 ​60.24
​Beneficiaries with diabetes who met all of the following criteria not in operations ​not in operations ​28.97 ​25.41
​(ACO-22) ​Hemoglobin A1c Control (HbA1c)
(<8 percent) 
not in operations ​not in operations ​72.52 N/A
​(ACO-23) ​Low Density Lipoprotein (LDL) (< 100 mg/dL)  not in operations ​not in operations ​55.30 N/A
​(ACO-24) ​Blood Pressure (BP) < 140/90  not in operations ​not in operations ​69.04 N/A
​(ACO-25) ​Tobacco Non-Use  not in operations ​not in operations ​96.19 N/A
​(ACO-26) ​Aspirin Use     not in operations ​not in operations ​89.60 N/A
​(ACO-27) ​Percent of beneficiaries with diabetes whose HbA1c in poor control (>9 percent)  not in operations ​not in operations ​16.56​ ​20.35
​(ACO-28) ​Percent of beneficiaries with hypertension whose BP < 140/90  not in operations ​not in operations ​67.70 ​68.02
​(ACO-29) ​Percent of beneficiaries with IVD with complete lipid profile and LDL control < 100mg/dl  not in operations ​not in operations ​47.80 ​57.29
​(ACO-30) ​Percent of beneficiaries who use Aspirin or other antithrombotic  not in operations ​not in operations ​ 88.51 ​80.79
​(ACO-31) ​Beta-Blocker Therapy for LVSD not in operations ​not in operations ​95.00 ​82.71
​Percent of beneficiaries with CAD who met all of the following criteria not in operations ​not in operations ​62.30 ​66.9
​(ACO-32) ​Drug Therapy for Lowering LDL-Cholesterol   not in operations ​not in operations 67.38 N/A
 (ACO-33)​ ​(ACE) Inhibitor or (ARB) Therapy for Patients with CAD and Diabetes and/or (LVSD) not in operations ​not in operations ​80.00 N/A
For more information on how to interpret scores on the above quality performance measures, see https://www.cms.gov/Medicare/Medicare-Fee-for-Service- Payment/sharedsavingsprogram/Downloads/MSSP-QM-Benchmarks.pdf​